Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.36), in-line with the analyst estimate of ($0.36).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance